ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(22 sites)
United Kingdom
Glan Clwyd Hospital, Bodelwyddan, Denbighshire Mount Vernon Hospital, The Hillingdon Hospitals NHS Foundation Trust, Northwood, Middlesex Aberdeen Royal Infirmary, NHS Grampian, Aberdeen Belfast City Hospital, Belfast Health and Social Care Trust, Belfast Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham Bristol Haematology & Oncology Centre, University Hospitals Bristol & Weston NHS Foundation Trust, Bristol Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge Velindre Cancer Centre, Velindre University NHS Trust, Cardiff Western General Hospital, NHS Lothian, Edinburgh Beatson West of Scotland Cancer Centre, NHS Greater Glasgow & Clyde, Glasgow Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, Hull St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds St Bartholomew's Hospital, Barts Health NHS Trust, London Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London Charing Cross Hospital, Imperial College Healthcare NHS Trust, London Maidstone Hospital, Maidstone and Tunbridge Wells NHS Trust, Maidstone The Christie Hospital, The Christie NHS Foundation Trust, Manchester Clatterbridge Cancer Centre, The Clatterbridge Cancer Centre NHS Foundation Trust, Metropolitan Borough of Wirral City Hospital, Nottingham University Hospitals NHS Trust, Nottingham Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford Derriford Hospital, University Hospitals Plymouth NHS Trust, Plymouth Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, Southampton Age range
16 Years and older
Last updated January 2026